Screening for germline or somatic POLE/POLD1–EDM variants, but also for variants in other genes recently described to be mutated in sLS CRCs such as BRCA1, BRCA2, ATM and CHEK2, may explain some of these sLS patients [59, 60]. This evidence concerns the gene ATM and Sjogren-Larsson syndrome.